MBNL3_HUMAN - dbPTM
MBNL3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MBNL3_HUMAN
UniProt AC Q9NUK0
Protein Name Muscleblind-like protein 3
Gene Name MBNL3
Organism Homo sapiens (Human).
Sequence Length 354
Subcellular Localization Nucleus . Cytoplasm . Greater concentration in the nucleus. In both DM1 and DM2 patients, colocalizes with nuclear foci of retained expanded-repeat transcripts.
Protein Description Mediates pre-mRNA alternative splicing regulation. Acts either as activator or repressor of splicing on specific pre-mRNA targets. Inhibits cardiac troponin-T (TNNT2) pre-mRNA exon inclusion but induces insulin receptor (IR) pre-mRNA exon inclusion in muscle. Antagonizes the alternative splicing activity pattern of CELF proteins. May play a role in myotonic dystrophy pathophysiology (DM). Could inhibit terminal muscle differentiation, acting at approximately the time of myogenin induction..
Protein Sequence MTAVNVALIRDTKWLTLEVCREFQRGTCSRADADCKFAHPPRVCHVENGRVVACFDSLKGRCTRENCKYLHPPPHLKTQLEINGRNNLIQQKTAAAMFAQQMQLMLQNAQMSSLGSFPMTPSIPANPPMAFNPYIPHPGMGLVPAELVPNTPVLIPGNPPLAMPGAVGPKLMRSDKLEVCREFQRGNCTRGENDCRYAHPTDASMIEASDNTVTICMDYIKGRCSREKCKYFHPPAHLQARLKAAHHQMNHSAASAMALQPGTLQLIPKRSALEKPNGATPVFNPTVFHCQQALTNLQLPQPAFIPAGPILCMAPASNIVPMMHGATPTTVSAATTPATSVPFAAPTTGNQLKF
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MTAVNVALI
------CCCEEEEEE
39.0330622161
13UbiquitinationVALIRDTKWLTLEVC
EEEECCCCEEHHHHH
44.49-
36UbiquitinationSRADADCKFAHPPRV
CCCCCCCCCCCCCCE
46.2429967540
59UbiquitinationVACFDSLKGRCTREN
EEEECCCCCCCCHHC
48.5429967540
59AcetylationVACFDSLKGRCTREN
EEEECCCCCCCCHHC
48.5426051181
68UbiquitinationRCTRENCKYLHPPPH
CCCHHCCCCCCCCCC
63.53-
77UbiquitinationLHPPPHLKTQLEING
CCCCCCCEEEEEECC
31.06-
134UbiquitinationPPMAFNPYIPHPGMG
CCCCCCCCCCCCCCC
28.3429967540
147UbiquitinationMGLVPAELVPNTPVL
CCCCCHHHCCCCCEE
9.3629967540
173UbiquitinationAVGPKLMRSDKLEVC
CCCCHHHCCCHHHHH
52.7429967540
180UbiquitinationRSDKLEVCREFQRGN
CCCHHHHHHHHHCCC
2.2329967540
193UbiquitinationGNCTRGENDCRYAHP
CCCCCCCCCCCCCCC
57.4129967540
219UbiquitinationTVTICMDYIKGRCSR
EEEECHHHHCCCCCH
4.2529967540
230UbiquitinationRCSREKCKYFHPPAH
CCCHHHCCCCCCHHH
63.1229967540
243UbiquitinationAHLQARLKAAHHQMN
HHHHHHHHHHHHHCC
37.6629967540
269UbiquitinationGTLQLIPKRSALEKP
CCEEEECCCCCCCCC
52.5729967540

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of MBNL3_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MBNL3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MBNL3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of MBNL3_HUMAN !!

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MBNL3_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP